PerkinElmer Elects Samuel Chapin to Board of Directors

03:00 EDT 19 Oct 2016 | Bionity

PerkinElmer, Inc. announced that Samuel R. Chapin has been elected to the Company's Board of Directors. "I am pleased to welcome Samuel to our Board, as he brings extensive experience in strategic advisory, mergers and acquisitions, and deal financing for a wide range of transactions, along with dee...

Original Article: PerkinElmer Elects Samuel Chapin to Board of Directors


More From BioPortfolio on "PerkinElmer Elects Samuel Chapin to Board of Directors"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.